Brind.

Elizabeth O’Farrell was appointed to the board of SpyGlass Pharma, which is led by CEO Patrick Mooney. Elizabeth previously gained experience at Eli Lilly.

1 report, 1 independent Updated Aug 19

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Elizabeth Spyglass Patrick Mooney Eli Lilly and Company

Keep exploring

The entities involved

Elizabeth
Nothing else this week.
Spyglass
company
- Production issues related to comments about Palestine are causing fallout for Scream 7.Sat 19:31
Patrick Mooney
researcher

Nothing else this week.
Eli Lilly and Company
American pharmaceutical company
- ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
- The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59

Coverage

Newest first; wire copies grouped

Aug 19GlobeNewswireSpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, toda